2. Andersson Т., Rohss K., Hassan-Alin M. Pharmacokinetics (PK) and dose-response relationship of esomeprazole (E) // Gastroenterology. - 2000. - № 118. - Р. A1210.
3. Castell D., Kahrilas P. et al. Esomeprazole provides more effective healing than lansoprazole in GERD patients with erosive oesophagitis // Gut. - 2001. - Vol. 49 (suppl. Ill). - P. A3363.
4. Hassan-Alin M., Andersson Т., Bredberg E. et al. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects // Eur. J. Clin. Pharmacol. - 2000. - № 56. - P. 665-670.
5. Hasselgren G., Hassan-Alin M., Andersson T. et al. Pharmacokinetic study of esomeprazole in the elderly // Clin. Pharmacokinet. - 2001. - № 40. - P. 145-150.
6. Hawkey C.J., Talley N.J., Scheiman J.M. et al. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies // Arthritis Res. Ther. - 2007. - № 9. - P. R17.
7. Horai Y., Kimura M., Furuie H. et al. Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes // Aliment. Pharmacol. Ther. - 2001. - № 15. - P. 805-812.
8. Johnson D., Benjamin S., Vakil N. et al. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive eosophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety // Amer. J. Gastroenterol. - 2001. - № 96. - P. 27-34.
9. Junghard O., Hassan-Alin M., Hasselgren G. The effect of AUC and Cmax of esomeprazole on acid secretion and intragastric pH // Gastroenterology. - 2000. - № 118. - P. A17.
10. Lind Т., Rydberg L., Kyleback A. et al. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease // Aliment. Pharmacol. Ther. - 2000. - № 14. - P. 861-867.
11. Metz D.C., Sostek M.B., Ruszniewski P. et al. Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion // Am. J. Gastroenterol. - 2007; in press.
12. Richter J., Kahrilas P., Johanson J. et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial // Am. J. Gastroenterol. - 2001. - № 96. - P. 656-665.
13. Rohss K., Claar-Nilsson C., Rydholm H. Esomeprazole 40 mg provides more effective acid control than lansoprazole 30 mg // Gastroenterology. - 2000. - № 118. - P. A20.
14. Rohss K., Lind T., Wilder-Smith C. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms // Eur. J. Clin. Pharmacol. - 2004. - № 60. - P. 531-539.
15. Subei I.M., Cardona H.J., Bachelet E. et al. One week of esomeprazole triple therapy vs. 1 week of omeprazole triple therapy plus 3 weeks of omeprazole for duodenal ulcer healing in Helicobacter pylori-positive patients // Dig. Dis. Sci. - 2007. - № 52 (6). - P. 1505-1512.
16. Talley N., Venables Т., Green J. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative GERD: a placebo-controlled trial of on-demand therapy for 6 months // Gastroenterology. - 2000. - № 118. - P. A658.
17. Tulassay Z., Kryszewski A., Dite P. et al. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease // Eur. J. Gastroenterol. Hepatol. - 2001. - № 3. - P.1457-1465.
18. Vakil N., Shaker R., Johnson D. et al. The new proton pump inhibitor esomeprazole is effective as a maintanence therapy in GERD patients with healed erosive eosophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety // Aliment. Pharmacol. Ther. - 2001. - № 15. - P. 927-935.
19. Veldhuyzen van Zanten S., Lauritsen K., Delchier J.-C. et al. One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease // Aliment. Pharmacol. Ther. - 2000. - № 14. - P.1605-1611.
20. Wilder-Smith C., Rohss K., Lundin C. Esomeprazole (E) 40 mg provides more effective acid control than pantoprazole (P) 40 mg // Gastroenterology. - 2000. - № 118. - P. A22.